Literature DB >> 17030621

Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity.

Wanping Xu1, Xitong Yuan, Kristin Beebe, Zhexin Xiang, Len Neckers.   

Abstract

The receptor tyrosine kinase ErbB2 plays a crucial role in tumorigenesis. We showed previously that the molecular chaperone Hsp90 protects ErbB2 from proteasome-mediated degradation by binding to a short loop structure in the N-lobe of the kinase domain. Here we show that loss of Hsp90 binding correlates with enhanced ErbB2 kinase activity and its transactivating potential, concomitant with constitutively increased phosphorylation of Tyr877, located in the activation loop of the kinase domain. We show further that Tyr877 phosphorylation is mediated by Src and that it is necessary for the enhanced kinase activity of ErbB2. Finally, computer modeling of the kinase domain suggests a phosphorylation-dependent reorientation of the activation loop, denoting the importance of Tyr877 phosphorylation for ErbB2 activity. These findings suggest that Hsp90 binding to ErbB2 participates in regulation of kinase activity as well as kinase stability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030621      PMCID: PMC1800645          DOI: 10.1128/MCB.00899-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

Review 1.  Cellular functions regulated by Src family kinases.

Authors:  S M Thomas; J S Brugge
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

2.  Molecular modeling of nearly full-length ErbB2 receptor.

Authors:  Péter Bagossi; Gábor Horváth; György Vereb; János Szöllösi; József Tözsér
Journal:  Biophys J       Date:  2004-12-13       Impact factor: 4.033

Review 3.  Src kinase regulation by phosphorylation and dephosphorylation.

Authors:  Robert Roskoski
Journal:  Biochem Biophys Res Commun       Date:  2005-05-27       Impact factor: 3.575

4.  Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation.

Authors:  Ami Citri; Judith Gan; Yaron Mosesson; Gyorgi Vereb; Janos Szollosi; Yosef Yarden
Journal:  EMBO Rep       Date:  2004-12       Impact factor: 8.807

5.  c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function.

Authors:  J S Biscardi; M C Maa; D A Tice; M E Cox; T H Leu; S J Parsons
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

6.  Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.

Authors:  Wanping Xu; Xitong Yuan; Zhexin Xiang; Edward Mimnaugh; Monica Marcu; Len Neckers
Journal:  Nat Struct Mol Biol       Date:  2005-01-09       Impact factor: 15.369

7.  Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.

Authors:  Simone Diermeier; Gábor Horváth; Ruth Knuechel-Clarke; Ferdinand Hofstaedter; János Szöllosi; Gero Brockhoff
Journal:  Exp Cell Res       Date:  2005-01-21       Impact factor: 3.905

8.  A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains.

Authors:  Meytal Landau; Sarel J Fleishman; Nir Ben-Tal
Journal:  Structure       Date:  2004-12       Impact factor: 5.006

9.  CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation.

Authors:  Neslihan Cabioglu; Justin Summy; Claudia Miller; Nila U Parikh; Aysegul A Sahin; Sitki Tuzlali; Kevin Pumiglia; Gary E Gallick; Janet E Price
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

10.  Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential.

Authors:  H T Zhang; D M O'Rourke; H Zhao; R Murali; Y Mikami; J G Davis; M I Greene; X Qian
Journal:  Oncogene       Date:  1998-06-04       Impact factor: 9.867

View more
  33 in total

1.  Deconstructing honeybee vitellogenin: novel 40 kDa fragment assigned to its N terminus.

Authors:  Heli Havukainen; Øyvind Halskau; Lars Skjaerven; Bente Smedal; Gro V Amdam
Journal:  J Exp Biol       Date:  2011-02-15       Impact factor: 3.312

2.  ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.

Authors:  Keneshia K Haenssen; Sarah A Caldwell; Kristina S Shahriari; S Raelle Jackson; Kelly A Whelan; Andres J Klein-Szanto; Mauricio J Reginato
Journal:  J Cell Sci       Date:  2010-03-23       Impact factor: 5.285

3.  Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3.

Authors:  Wendy Béguelin; María Celeste Díaz Flaqué; Cecilia J Proietti; Florencia Cayrol; Martín A Rivas; Mercedes Tkach; Cinthia Rosemblit; Johanna M Tocci; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Journal:  Mol Cell Biol       Date:  2010-09-27       Impact factor: 4.272

4.  Binding-induced, turn-on fluorescence of the EGFR/ERBB kinase inhibitor, lapatinib.

Authors:  James N Wilson; Wenjun Liu; Adrienne S Brown; Ralf Landgraf
Journal:  Org Biomol Chem       Date:  2015-05-07       Impact factor: 3.876

Review 5.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.

Authors:  M M Moasser
Journal:  Oncogene       Date:  2007-04-30       Impact factor: 9.867

6.  Geldanamycin selectively targets the nascent form of ERBB3 for degradation.

Authors:  Candice S Gerbin; Ralf Landgraf
Journal:  Cell Stress Chaperones       Date:  2010-01-19       Impact factor: 3.667

Review 7.  Impact of heat-shock protein 90 on cancer metastasis.

Authors:  Shinji Tsutsumi; Kristin Beebe; Len Neckers
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

8.  Atomistic insights into regulatory mechanisms of the HER2 tyrosine kinase domain: a molecular dynamics study.

Authors:  Shannon E Telesco; Ravi Radhakrishnan
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

9.  Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer.

Authors:  B L Allen-Petersen; C J Carter; A M Ohm; M E Reyland
Journal:  Oncogene       Date:  2013-03-11       Impact factor: 9.867

10.  Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.

Authors:  Prudence B Lam; Laura N Burga; Bryan P Wu; Erin W Hofstatter; Kun Ping Lu; Gerburg M Wulf
Journal:  Mol Cancer       Date:  2008-12-15       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.